CHA AI Healthkare차AI헬스케어
025620 · KOSPI · ₩025620 · 차AI헬스케어
Valuation model · Discounted cash flow (DCF)
We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.
Fair value per share
With these assumptions the model gives no positive value.
- Enterprise value
- −₩34B
- Equity value
- −₩63B
- WACC
- 6.5%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.
Why the model and the price differ
The model gives no positive value at these assumptions. What we can see:
- To match today's price of ₩5,060, the model needs an operating margin of 81.5% every year (it uses −20.0%).
- Margins ranged from −170.8% to −34.7% over the last 5 years, so this is a cyclical business. The model uses the average; the price may be set by where the cycle is now. Try the margin fade option.
- 100% of the last 12 months' net profit came from outside operations (stakes in other companies, interest, one-offs). The model adds those stakes at book value but doesn't project that income.
- In the projection, spending on equipment, software and working capital takes most or all of the after-tax operating profit, so free cash flow is thin. Companies that invest heavily often look like this until spending slows.
- The group includes a financial business (an insurer, bank or broker), whose investments and minority shareholders are left out here. A sum-of-the-parts view usually fits groups like this better.
Treat the model as a starting point: change the assumptions to the story you believe, and compare with the multiples check below.
Bear / Base / Bull
- Bear
- —
- Base
- —
- Bull
- —
Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.
Assumptions
Sign in to change the assumptions and see the results update. Sign in
Cycle options
Margin path
Every year uses the cycle-average margin (−20.0%).
Revenue growth
- 5.4%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (5.4% a year, annual reports), fading to 3% by year 5.
- 4.8%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (5.4% a year, annual reports), fading to 3% by year 5.
- 4.2%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (5.4% a year, annual reports), fading to 3% by year 5.
- 3.6%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (5.4% a year, annual reports), fading to 3% by year 5.
- 3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (5.4% a year, annual reports), fading to 3% by year 5.
Business
- -20%
Operating profit as a share of revenue.
Default: through-the-cycle average of the last 12 months and the last 5 annual reports' operating margins.
- 27.5%
Share of operating profit paid as corporate tax.
Default: Korea's top corporate tax rate (25%) plus 10% local income tax.
- 3.3%
The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).
Default: not in the statements, so 80% of capital spending (most spending replaces equipment that wears out).
- 4.2%
Money spent on factories, equipment, software and other long-term assets (% of revenue).
Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).
- 40%
Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.
Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 3 years.
Discount rate
- 2%
How fast cash flows keep growing every year after year 5.
Default: about Korea's long-run inflation plus real growth.
- 4.01%
Yield on Korea's 10-year government bond: the return with almost no risk.
Default: Korea Treasury Bond 10-year yield on 2026-10-30.
- 0.6
How much the share moves when the market moves: 1 means just like the market.
Default: 104 weeks of weekly returns against KOSPI (official index); raw beta 0.37, adjusted toward 1 and kept between 0.6 and 2.0.
- 5.5%
The extra return investors want for owning shares instead of bonds.
Default: a typical premium for Korean shares.
- 5.51%
The interest rate the company would pay to borrow.
Default: the 10-year yield plus a 1.5% credit spread.
Starting point
- Revenue (TTM to H1 2026)
- ₩8.4B
- Net debt (borrowings and leases − cash and deposits)
- ₩30B
- Shares
- 18,203,973
- Share price
- ₩5,060
- Market cap
- ₩92B
TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.
Past years and projection
Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.
| FY2023 | FY2024 | FY2025 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩17B | ₩16B | ₩7.3B | ₩8.9B | ₩9.3B | ₩9.7B | ₩10B | ₩10B |
| Growth | 172.7% | −8.0% | −53.4% | 5.4% | 4.8% | 4.2% | 3.6% | 3.0% |
| EBIT | −₩10B | −₩5.4B | −₩7.5B | −₩1.8B | −₩1.9B | −₩1.9B | −₩2B | −₩2.1B |
| EBIT margin | −59.8% | −34.7% | −102.1% | −20.0% | −20.0% | −20.0% | −20.0% | −20.0% |
| After-tax EBIT | −₩7.4B | −₩3.9B | −₩5.4B | −₩1.3B | −₩1.4B | −₩1.4B | −₩1.5B | −₩1.5B |
| + Depreciation | — | — | — | ₩293M | ₩307M | ₩320M | ₩332M | ₩342M |
| − Capital spending | ₩472M | ₩244M | ₩600M | ₩373M | ₩391M | ₩408M | ₩422M | ₩435M |
| − Working capital | −₩47M | −₩1.5B | ₩135M | ₩182M | ₩171M | ₩157M | ₩140M | ₩121M |
| Free cash flow | — | — | — | −₩1.6B | −₩1.6B | −₩1.7B | −₩1.7B | −₩1.7B |
| Discount factor | — | — | — | 0.939 | 0.882 | 0.828 | 0.777 | 0.730 |
| Present value | — | — | — | −₩1.5B | −₩1.4B | −₩1.4B | −₩1.3B | −₩1.3B |
Terminal value −₩37B, worth −₩27B today: 80% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.
Cross-check: what the market has paid before
For cyclical businesses, analysts check a DCF against the multiples the stock has traded at through past cycles. Price / book is the usual anchor for them: P/E looks highest at the bottom of a cycle, when earnings are smallest, and lowest at the top. The price each band would give today:
| Low | Typical | High | |
|---|---|---|---|
| Price / book (book value ₩4,449 a share)Now 1.14× | ₩9,1392.05× | ₩13,1452.95× | ₩25,7165.78× |
Low, typical and high are the 10th percentile, middle and 90th percentile of month-end multiples since 2021, each against the latest report out by then, per share at today's share count; loss years and P/E above 100 are left out. Run-rate earnings are one quarter × 4, not a forecast. Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Sensitivity
Fair value per share as two inputs change; the middle is the current case.
| WACC ↓ · Terminal growth → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 5.5% | — | — | — | — | — |
| 6.0% | — | — | — | — | — |
| 6.5% | — | — | — | — | — |
| 7.0% | — | — | — | — | — |
| 7.5% | — | — | — | — | — |
Now (TTM)
- Market cap
- ₩92B
- Enterprise value
- ₩121B
- P/E
- 11.3×
- P/B
- 1.1×
- P/S
- 10.9×
- EV/EBITDA
- —
- Dividend yield
- 0.0%
Over time (at each year end)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Price | ₩10,660 | ₩3,840 | ₩5,410 | ₩6,030 | ₩19,884 |
| Market cap | ₩194B | ₩70B | ₩98B | ₩110B | ₩362B |
| P/E | 142.0× | — | — | — | — |
| P/B | 2.6× | 2.4× | 2.5× | 2.6× | 6.1× |
| P/S | 26.6× | 4.5× | 5.8× | 17.6× | 17.6× |
| EV/EBITDA | — | — | — | — | — |
| Dividend yield | 0.0% | — | — | — | — |
Versus similar companies
| Company | P/E | P/B | P/S | EV/EBITDA | Dividend yield |
|---|---|---|---|---|---|
| CHA AI Healthkare | 11.3× | 1.1× | 10.9× | — | 0.0% |
| LG Chem | — | 0.5× | 0.3× | — | 0.9% |
| Hanwha Solutions | — | 0.5× | 0.3× | — | 0.0% |
| Hanwha | 5.9× | 0.4× | 0.1× | — | 1.5% |
| SKC | — | 1.8× | 1.7× | — | 0.0% |
| KCC | 0.9× | 0.3× | 0.5× | 8.9× | 0.0% |
| Kumho Petro Chemical | 5.3× | 0.4× | 0.4× | — | 1.6% |
| Similar companies (median) | 5.3× | 0.4× | 0.4× | 8.9× | 0.4% |
Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.
Also known as: CHA AI Healthkare / 차AI헬스케어 / 025620 / KRX:025620
Source: KRX statistical information